SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific board to consider dividend

06 Nov 2017 Evaluate

With reference to letter dated October 27, 2017 for intimation of Board Meeting scheduled to be held on November 9, 2017 to consider the unaudited financial results of the Company for the quarter ended September 30, 2017, Sequent Scientific has informed that the Board of Directors shall also consider the declaration of Interim dividend, if any, for the financial year 2017-18, at the aforesaid Meeting.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×